HOLOGIC INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-09: Form 8-K; Period of report 2022-12-08; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2022-11-04: Form 8-K; Period of report 2022-11-01; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2022-10-31: Form 8-K; Period of report 2022-10-31; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2022-09-23: Form 8-K; Period of report 2022-09-22; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-12-09 | 8-K | 2022-12-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 8, 2022, the Board of Directors of Hologic, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, increased the size of the Board from eight to nine directors and appointed Stacey D. Stewart as a director of the Company, effective January 2, 2023. | a53033137.htm |
| 2022-11-04 | 8-K | 2022-11-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Approval of revised forms of Performance Stock Unit (“PSU”) Award Agreements. | d409217d8k.htm |
| 2022-10-31 | 8-K | 2022-10-31 | 2.02 Results of Operations and Financial Condition | 2.02 On October 31, 2022, Hologic, Inc. issued a press release announcing its financial results for the fourth quarter and year ended September 24, 2022. | a52955715.htm |
| 2022-09-23 | 8-K | 2022-09-22 | 8.01 Other Events | 8.01 On September 22, 2022, the Board of Directors of Hologic, Inc. (the “Company”) authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.0 billion of the Company’s outstanding common stock, effective as of the close of trading on the NASDAQ Stock Market LLC on September 23, 2022. | a52923581.htm |
| 2022-08-30 | 8-K | 2022-08-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) Executive Officer Departure. | d395441d8k.htm |
| 2022-07-27 | 8-K | 2022-07-27 | 2.02 Results of Operations and Financial Condition | 2.02 On July 27, 2022, Hologic, Inc. issued a press release announcing its financial results for the third quarter ended June 25, 2022. | a52793001.htm |
| 2022-04-27 | 8-K | 2022-04-27 | 2.02 Results of Operations and Financial Condition | 2.02 On April 27, 2022, Hologic, Inc. issued a press release announcing its financial results for the second quarter ended March 26, 2022. | a52698812.htm |
| 2022-03-11 | 8-K | 2022-03-10 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The Company’s Annual Meeting of Stockholders was held on March 10, 2022. | holx-20220310.htm |
| 2022-02-02 | 8-K | 2022-02-02 | 2.02 Results of Operations and Financial Condition | 2.02 On February 2, 2022, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 25, 2021. | a52572748.htm |
| 2022-01-10 | 8-K | 2022-01-09 | 2.02 Results of Operations and Financial Condition | 2.02 On January 9, 2022, Hologic, Inc. issued a press release announcing its preliminary revenue results for the first quarter ended December 25, 2021. | a52559882.htm |